Related Experiment Video
Updated: Aug 22, 2026
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Target discovery in metabolic disease
1DeveloGen AG, Rudolf-Wissell Strasse 28, 37079 Goettingen, Germany. dohrmann@develogen.com
Abstract:
The prevalence of metabolic diseases is taking on epidemic proportions and poses a serious threat to human health. Current treatment options have proven insufficient to cope with obesity and diabetes because they rarely restore normal metabolism and thus leave patients exposed to life-threatening complications. Successful management of these diseases depends on novel, improved therapeutic strategies targeting early intervention in disease progression. Discovery of novel metabolic disease targets has been hampered by the complexity of contributing environmental and genetic factors, as well as the need for potent but safe treatments suitable for chronic diseases. Genomic approaches are excellent tools to manage genetic complexity and have been applied successfully to identify candidate target genes that will lead to the development of novel therapies for metabolic diseases.
Insights
Metabolic diseases like obesity and diabetes are increasing. Genomic approaches can identify new targets for effective treatments to manage these complex conditions.
Area of Science:
- Biomedical Science
- Genetics
- Metabolic Disease Research
Background:
- Metabolic diseases, including obesity and diabetes, are a growing global health concern.
- Existing treatments are often insufficient, failing to restore normal metabolism and leaving patients vulnerable to severe complications.
- Developing novel therapeutic strategies for early intervention is crucial for effective disease management.
Purpose of the Study:
- To highlight the limitations of current treatments for metabolic diseases.
- To emphasize the need for novel therapeutic targets and strategies.
- To underscore the potential of genomic approaches in identifying these targets.
Main Methods:
- Reviewing the challenges in metabolic disease target discovery.
- Discussing the role of genetic and environmental factors.
- Evaluating the application of genomic approaches.
Main Results:
- Genomic approaches offer a powerful tool to address the genetic complexity of metabolic diseases.
- These methods have been successful in identifying candidate target genes.
- This facilitates the development of new therapies.
Conclusions:
- Genomic strategies are essential for overcoming the complexity of metabolic diseases.
- Identifying novel therapeutic targets through genomics is key to developing improved treatments.
- This research supports the advancement of therapies for metabolic disorders.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
01:26Drug Discovery: Overview